301 results about "Proper treatment" patented technology

The present invention relates to methods for determining meniscal size and shape for use in designing therapies for the treatment of various joint diseases. The invention uses an image of a joint that is processed for analysis. Analysis can include, for example, generating a thickness map, a cartilage curve, or a point cloud. This information is used to determine the extent of the cartilage defect or damage and to design an appropriate therapy, including, for example, an implant. Adjustments to the designed therapy are made to account for the materials used.

The present invention relates to methods for the diagnosis, evaluation, and treatment of mood disorders, particularly bipolar disorder. In particular, patient test samples are analyzed for the presence and amount of members of a panel of biallelic markers comprising one or more specific markers for bipolar treatment and one or more non-specific markers for bipolar treatment. A variety of markers are disclosed for assembling a panel of markers for such diagnosis and evaluation. Algorithms for determining proper treatment are disclosed. A diagnostic kit for a panel of said markers is disclosed. In various aspects, the invention provides methods for the early detection and differentiation of mood disorders or bipolar treatment. Methods for screening therapeutic compounds for mood disorders are disclosed. The invention (1) gives methods providing rapid, sensitive and specific assays that can greatly increase the number of patients that can receive beneficial treatment and therapy, thereby reducing the costs associated with incorrect diagnosis, and (2) provides methods for improved therapies.

The present invention relates to methods for the diagnosis and evaluation of cardiovascular illness, particularly stroke, myocardial and other cardiovascular damage damage, hypertension treatment. In particular, patient test samples are analyzed for the presence and amount of members of a panel of markers comprising one or more specific markers for cardiovascular illness or hypertension treatment and one or more non-specific markers for cardiovascular illness or hypertension treatment. A variety of markers are disclosed for assembling a panel of markers for such diagnosis and evaluation. Algorithms for determining proper treatment are disclosed. A diagnostic kit for a panel of said markers is disclosed. In various aspects, the invention provides methods for the early detection and differentiation of cardiovascular illness or hypertension treatment. Invention methods provide rapid, sensitive and specific assays that can greatly increase the number of patients that can receive beneficial treatment and therapy, reduce the costs associated with incorrect diagnosis, and provide important information about the prognosis of the patient.

This invention is an improved method and device for treating varicose veins 200 or the greater saphenous vein 202. The method comprises the use of infrared laser radiation in the region of 1.2 to 2.2 um in a manner from inside the vessel 200 or 202 such that the endothelial cells of the vessel wall 704 are damaged and collagen fibers in the vessel wall 704 are heated to the point where they permanently contract, the vessel 200 or 202 is occluded and ultimately resorbed. The device includes a laser 102 delivered via a fiber optic catheter 300 that may have frosted or diffusing fiber tips 308, or that may be provided with a protective spacer. A motorized pull back device 104 may be used, and a thermal sensor 600 may be used to help control the power required to maintain the proper treatment temperature.

A method and apparatus for facilitating placement and evaluation of virtual appliances on virtual teeth of an orthodontic patient are described. Positioning references comprising bracket height, occlusal plane, or any arbitrary plane are provided to facilitate desired placement of virtual appliances on virtual teeth model. The process can be applied with any dentition state of a patient such as malocclusion, target state from treatment, or intermediate monitored state during the course of a treatment. An unified workstation for treatment planning provides the computer software tools for verification, simulation and evaluation of the virtual appliance placement. The process enables proper planning of treatment for an orthodontic patient suffering from malocclusion involving bonding of virtual brackets to the surface of the patient's virtual teeth with archwires placed in the slots of the brackets, so as to realize the desired results from the treatment in the most desired manner.

Methods and arrangements for virtual private network (VPN) data packets are disclosed. VPN packets include a payload having Internet Protocol (IP) addresses which guide the packet through a network to a security gateway. The payload may be encrypted and/or compressed and may include internal addresses to denote the real source and destination for a data portion of the payload. As initial control packets are received they are authenticated and rules and procedures are identified for proper treatment of VPN data packets bearing the same source IP address. The rules and procedures are stored in a gateway data engine having a plurality of protocol processing modules. VPN data packets are received by a protocol discriminator which reads the stored rules and procedures identified for the source IP address of the received packet. The discriminator passes the received packet to a first protocol module as identified in the stored rules and procedures. After the first module completes processing, the packet is passed back to the protocol discriminator which determines whether further protocol processing is required. When further protocol processing is required, the packet is passed to another protocol module for processing in accordance with another protocol. At the completion of processing, the second protocol module returns the packet to the protocol discriminator.

An implantable neurostimulator system adapted to provide therapy for various neurological disorders is capable of varying therapy delivery strategies based on the context, physiological or otherwise, into which the therapy is to be delivered. Responsive and scheduled therapies can be varied depending on various sensor measurements, calculations, inferences, and device states (including elapsed times and times of day) to deliver an appropriate course of therapy under the circumstances.

Methods and apparatus are provided for determining a defibrillation treatment protocol in an external defibrillator using a measurement of elapsed time. The present invention provides a defibrillator with a timer function. Upon activation of the defibrillator, an internal timer begins to run. By closely associating the activation of the defibrillator with the onset of the patient's attack, and by making allowances for inherent time differences between these events, the timer provides a measure of the elapsed time between the onset of the patient's emergency and the presentation of the defibrillator at the patient's side. Using this measure of elapsed time, the defibrillator determines an appropriate treatment therapy, such as CPR or defibrillation therapy.

Protected software, such as an application and/or DLL, is monitored by protective software to guard against attacks, while distinguishing spurious, benign events from attacks. In a 1-touch approach, the protected software is monitored in a testing environment to detect spurious, benign events caused by, e.g., incompatibility or interoperability problems. The spurious events can be remediated in different ways, such as by applying a relaxed security policy. In a production mode, or 0-touch mode, when the protected software is subject to attacks, the corresponding remediation can be applied when the spurious events are again detected. Security events which occur in production mode can also be treated as benign when they occur within a specified time window. The applications and/or DLLs can further be classified according to whether they are known to have bad properties, known to be well-behaved, or unknown. Appropriate treatment is provided based on the classification.

A system and method are provided for monitoring the condition of the skeletal system and adjusting a treatment device to provide appropriate treatment in response to the sensed signal. More particularly, in one aspect the present invention is directed to a sensor for detecting changes at a spinal level and a dynamic treatment system adjustable in response to the detected changes.

An interactive computer assisted method compiles comprehensive health care information on patients in a central repository, assesses and analyzes this information, and identifies high utilizers of health care services using a computer and a user associated therewith. The method includes the steps of creating a central repository of various databases containing patient information, including demographic information and behavior, and optionally the results of a core survey of health status questions. The invention optionally involves the step of determining the appropriate core questions and the criteria to determine whether and when to ask certain questions of particular patients based on their response to prior questions. The invention accurately predicts risk of a medical condition or progression of a medical condition utilizing an interactive administration of a set of core survey questions combined with diagnostic data and places patients efficiently, reliably, and accurately into the appropriate treatment intervention programs. The invention eliminates redundant, repetitive surveying of patients with multiple medical conditions.

A method of assessing the ongoing kidney status of a mammal afflicted with or at risk of developing chronic renal injury or disease, including chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in urine, serum or plasma samples at discrete time periods, as well as over time. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening chronic renal disease or CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.

The process of cultivating haemtococcus pluvialis and producing astaxanthin includes compounding culture medium, one-step production process, circular use of the culture meidum and utilziing CO2 in regualting the pH value of culture liquid, inducing sporification of haemtococcus pluvialis and accumulating astaxanthin. The said process including cell growth of haemtococcus pulvalis, spore conversion and astaxanthin accumulation is completed in the same culture medium inside one identical bioreactor. The culture period may be shortened to 12-15 days, and the culture medium may be reused for at least six times via proper treatment. The production process has no effluent drainage, high astaxanthin yield and quality.

Disclosed is a novel plant cultivation method applicable to classification cultivation with simplified management, in which an enclosed box like container or greenhouse like space provides an enclosed cultivation space having a bottom forming a water reservoir for collecting condensed water so as to realize natural circulation of water evaporation and convection, by which cultivation control and management is realized in an almost watering free manner. Further, arranged outside the enclosed space is a carbon dioxide generation device in connection with an air compressor, which through proper treatment of drying and heating, supplies the interior cultivation space with pressurization and supplement of carbon dioxide and nutrients through piping arrangement, whereby the growth of plants can carry out completely free of pest damage or application of pesticides. Through the control of sunlight, the growth and cultivation of plants can be realized in a management simplified, secured, and stable manner.

The invention discloses a method for treating desulfurization ash. The method comprises the following steps of: mixing the desulfurization ash generated by a dry/semidry desulphurization process and limestone powder, which serve as raw materials of a desulfurizer in a wet flue gas desulfurization process, according to a proportion; uniformly stirring the desulfurizer and pumping the desulfurizer into a slurry pond of an absorption tower; adding a catalyst into the slurry pond; introducing oxidation air into the slurry pond; introducing flue gas into the slurry pond through a flue; reacting the desulfurizer with SO2 in the flue gas under the action of the oxidation air and the catalyst; controlling the pH value of the slurry in the absorption tower, the slurry temperature, the content of solid matters contained in the slurry and the retention time of the desulfurizer in the slurry pond; after the reaction is completed, performing vortex concentration and vacuum filtration to obtain a gypsum by-product; and adding wastewater produced in the process into a process water collection box for recycling. The method is simple, is easy to realize, has remarkable effect, provides a safe and proper treatment way for the dry/semidry desulfurization ash and has good economic and social benefits.

Methods of assessing the ongoing kidney status in a subject afflicted with chronic renal failure (CRF) by detecting the quantity of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in fluid samples over time is disclosed. NGAL is a small secreted polypeptide that is protease resistant and consequently readily detected in the urine and serum as a result of chronic renal tubule cell injury. Incremental increases in NGAL levels in CRF patients over a prolonged period of time are diagnostic of worsening kidney disease. This increase in NGAL precedes and correlates with other indicators of worsening CRF, such as increased serum creatinine, increased urine protein secretion, and lower glomerular filtration rate (GFR). Proper detection of worsening (or improving, if treatment has been instituted) renal status over time, confirmed by pre- and post-treatment NGAL levels in the patient, can aid the clinical practitioner in designing and/or maintaining a proper treatment regimen to slow or stop the progression of CRF.

The present invention concerns methods and compositions for identifying genes or genetic pathways modulated by miR-16, using miR-16 to modulate a gene or gene pathway, using this profile in assessing the condition of a patient and/or treating the patient with an appropriate miRNA.